Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ACPP Produits

(Acid Phosphatase, Prostate (ACPP))

Catégories

This gene encodes a multidomain protein containing an N-terminal alpha-helical region with a coiled-coil motif, followed by a pleckstrin homology (PH) domain, an Arf-GAP domain, an ankyrin homology region, a proline-rich region, and a C-terminal Src homology 3 (SH3) domain. The protein localizes in the Golgi apparatus and at the plasma membrane, where it colocalizes with protein tyrosine kinase 2-beta (PYK2). The encoded protein forms a stable complex with PYK2 in vivo. This interaction appears to be mediated by binding of its SH3 domain to the C-terminal proline-rich domain of PYK2. The encoded protein is tyrosine phosphorylated by activated PYK2. It has catalytic activity for class I and II ArfGAPs in vitro, and can bind the class III Arf ARF6 without immediate GAP activity. The encoded protein is believed to function as an ARF GAP that controls ARF-mediated vesicle budding when recruited to Golgi membranes. In addition, it functions as a substrate and downstream target for PYK2 and SRC, a pathway that may be involved in the regulation of vesicular transport. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2008].

antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.

Catégories ACPP en vedette

ACPP Anticorps

High quality antibodies with extensive validation data.

ACPP Kits ELISA

Reliable ELISA kits for a wide range of species.

ACPP Protéines

Proteins for various applications incl. WB, ELISA, IF etc.

ACPP recommandé Anticorps

Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Application WB, IHC, IP, ICC
Validations
  • (9)
N° du produit ABIN7431248
Quantité 100 μL
Fiche technique Fiche technique
Reactivity Mouse
Application WB, IHC, IP, ICC
Validations
  • (7)
N° du produit ABIN7438529
Quantité 100 μL
Fiche technique Fiche technique
Reactivity Human
Application WB, IHC, IF
Validations
  • (6)
N° du produit ABIN3022672
Quantité 100 μL
Fiche technique Fiche technique

ACPP recommandé Kits ELISA

Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity Rat
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN6964540
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Human
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN6953397
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Pig
Analytical Method Quantitative
Validations
N° du produit ABIN777999
Quantité 96 tests
Fiche technique Fiche technique

ACPP recommandé Protéines

Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Source Wheat germ
Validations
  • (1)
N° du produit ABIN1305691
Quantité 10 μg
Fiche technique Fiche technique
Reactivity Human
Source Wheat germ
Validations
  • (1)
N° du produit ABIN1305693
Quantité 10 μg
Fiche technique Fiche technique
Reactivity Mouse
Source HEK-293 Cells
Validations
  • (1)
N° du produit ABIN7320069
Quantité 100 μg
Fiche technique Fiche technique

Dernières publications sur nos produits ACPP

Shimazu, Munakata, Tashiro, Salama, Dhahri, Eiamboonsert, Ota, Onoda, Tsuda, Okada, Nakauchi, Heissig, Hattori: "Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndrome." dans: Blood, Vol. 130, Issue 1, pp. 59-72, (2017) (PubMed).

Kirschenbaum, Izadmehr, Yao, OConnor-Chapman, Huang, Gregoriades, Yakar, Levine: "Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases." dans: Endocrinology, Vol. 157, Issue 12, pp. 4526-4533, (2016) (PubMed).

Nousiainen, Quintero, Myöhänen, Voikar, Mijatovic, Segerstråle, Herrala, Kulesskaya, Pulkka, Kivinummi, Abo-Ramadan, Taira, Piepponen, Rauvala, Vihko: "Mice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations." dans: PLoS ONE, Vol. 9, Issue 5, pp. e97851, (2014) (PubMed).

Rizzardi, Rosener, Koopmeiners, Isaksson Vogel, Metzger, Forster, Marston, Tiffany, McCarthy, Turley, Warlick, Henriksen, Schmechel: "Evaluation of protein biomarkers of prostate cancer aggressiveness." dans: BMC cancer, Vol. 14, pp. 244, (2014) (PubMed).

Cotella, Hernandez-Enriquez, Duan, Wu, Gazula, Brown, Kaczmarek, Sesti: "An evolutionarily conserved mode of modulation of Shaw-like K? channels." dans: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 27, Issue 4, pp. 1381-93, (2013) (PubMed).

Kato, Nicholson, Neiman, Rantalainen, Holmes, Barrett, Uhlén, Nilsson, Spector, Schwenk: "Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model." dans: Proteome science, Vol. 9, pp. 73, (2011) (PubMed).

Spencer, Prince, Roberts, Prosser, Bradstock, Coyle, Gill, Horvath, Reynolds, Kennedy: "Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure." dans: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, Issue 11, pp. 1788-93, (2009) (PubMed).

Drake, White, Fuller, Igwe, Clements, Nyalwidhe, Given, Lance, Semmes: "Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease." dans: Journal of proteomics, Vol. 72, Issue 6, pp. 907-17, (2009) (PubMed).

Klyushnenkova, Kouiavskaia, Kodak, Vandenbark, Alexander: "Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase." dans: The Prostate, Vol. 67, Issue 10, pp. 1019-28, (2007) (PubMed).

Quintero, Araujo, Pulkka, Wirkkala, Herrala, Eskelinen, Jokitalo, Hellström, Tuominen, Hirvikoski, Vihko: "Prostatic acid phosphatase is not a prostate specific target." dans: Cancer research, Vol. 67, Issue 14, pp. 6549-54, (2007) (PubMed).

Synonymes et noms alternatifs relatifs à ACPP

acid phosphatase, prostate (ACPP), ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 (ASAP2), acid phosphatase, prostate (Acpp), prostatic acid phosphatase (CpipJ_CPIJ004002), prostatic acid phosphatase, putative (Smp_016640), acid phosphatase, prostate S homeolog (acpp.S), 5'-NT, A030005E02Rik, ACP-3, acp-3, ACP3, acp3, ACPP, Acpp11, acpt, AMAP2, CENTB3, DDEF2, FRAP, Lap, PAG3, PAP, pap, Pap-alpha, Ppal, RNACPP11, SHAG1

Protein level used designations for ACPP

  • 5'-nucleotidase
  • TMPase
  • ecto-5'-nucleotidase
  • prostatic acid phosphatase
  • prostatic acid phosphotase
  • thiamine monophosphatase
  • PYK2 C terminus-associated protein
  • arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2
  • centaurin, beta 3
  • development and differentiation enhancing factor 2
  • development and differentiation-enhancing factor 2
  • paxillin-associated protein with ARF GAP activity 3
  • pyk2 C-terminus-associated protein
  • fluoride-resistant acid phosphatase
  • lysosomal acid phosphatase
  • prostatic acid phosphatase (rPAP)
  • acid phosphatase, prostate
  • tyrosine acid phosphatase
  • prostatic acid phosphatase-like
  • testicular acid phosphatase homolog
Vous êtes ici:
Support technique